alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 12,551–12,575 of 27,380 studies, newest first · page 503 of 1096.

August 2019 25

  1. 2019-08-20

    Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic

    ✓ Peer-reviewed Tau biomarkers PloS one

    Key finding: Alzheimer's disease (AD) remains a clinical diagnosis but biomarkers from cerebrospinal fluid (CSF) and more lately amyloid imaging with positron emission tomography (PET), are important to support a diagnosis of AD. +3 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2019-08-20

    Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study

    ✓ Peer-reviewed Biomarkers The Lancet. Neurology

    Key finding: High and increasing blood pressure from early adulthood into midlife seems to be associated with increased WMHV and smaller brain volumes at 69-71 years of age. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2019-08-18

    Effect of computerised cognitive training on cognitive outcomes in mild cognitive impairment: a systematic review and meta-analysis

    ✓ Peer-reviewed Prevention trials BMJ open

    Key finding: This meta-analysis provides evidence that CCT improves cognitive function in older people with MCI. +1 more finding

    Full summary, score breakdown and related studies → Original source

  4. 2019-08-18

    Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota

    ✓ Peer-reviewed Getting a diagnosis Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: Patients with AD and MCI have decreased microbial diversity, and changes in gut microbiota could be detected for early detection of AD.

    Full summary, score breakdown and related studies → Original source

  5. 2019-08-17

    Souvenaid in the management of mild cognitive impairment: an expert consensus opinion

    ✓ Peer-reviewed Prevention trials Alzheimer's research & therapy

    Key finding: Early and accurate diagnosis of MCI provides a window of opportunity to improve the outcomes using a multimodal management approach including lifestyle risk factor modification and consideration of the multinutrient Souvenaid.

    Full summary, score breakdown and related studies → Original source

  6. 2019-08-17

    Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies

    ✓ Peer-reviewed How common it is Ageing research reviews

    Key finding: Diabetes, even prediabetes and changes of diabetes-related biochemical indicators, predicted increased incidence of cognitive impairment and dementia. +2 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2019-08-16

    Blood NfL: A biomarker for disease severity and progression in Parkinson disease

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: Plasma NfL levels correlated with disease severity and progression in terms of both motor and cognitive functions in PD. +3 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2019-08-16

    Cognitive dysfunction in diabetes: how to implement emerging guidelines

    ✓ Peer-reviewed Risk factors Diabetologia

    Key finding: Cognitive dysfunction, including mild cognitive impairment and dementia, is increasingly recognised as an important comorbidity and complication of diabetes that affects an individual's well-being and diabetes management, and is associated with diabetes treatment-related complications. +1 more finding

    Full summary, score breakdown and related studies → Original source

  9. 2019-08-16

    Effect of Long-Term Omega 3 Polyunsaturated Fatty Acid Supplementation with or without Multidomain Lifestyle Intervention on Muscle Strength in Older Adults: Secondary Analysis of the Multidomain Alzheimer Preventive Trial (MAPT)

    ✓ Peer-reviewed Treatments Nutrients

    Key finding: Low dose ω3-PUFA supplementation, either alone or in combination with a multidomain lifestyle intervention comprising physical activity counselling, had no significant effects on muscle strength over 3 years in elderly people. +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2019-08-16

    Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients

    ✓ Peer-reviewed Biomarkers Alzheimer's & dementia (New York, N. Y.)

    Key finding: The budgetary impacts are not insignificant but are small in comparison to the likely market price of any disease-modifying treatments or to the probable costs of missed or inaccurate diagnosis.

    Full summary, score breakdown and related studies → Original source

  11. 2019-08-14

    Suppression of gut dysbiosis by Bifidobacterium longum alleviates cognitive decline in 5XFAD transgenic and aged mice

    ✓ Peer-reviewed Disease mechanisms Scientific Reports

    Key finding: These findings suggest that the suppression of gut dysbiosis and LPS production by NK46 can mitigate cognitive decline through the regulation of microbiota LPS-mediated NF-κB activation.

    Full summary, score breakdown and related studies → Original source

  12. 2019-08-14

    Research, recruitment and observational data collection in care homes: lessons from the PACE study

    ✓ Peer-reviewed Health systems and care delivery BMC research notes

    Key finding: Multiple challenges were encountered in creating a sampling framework and contacting, recruiting and retaining care homes in the PACE study. +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2019-08-14

    Mobility assessment in people with Alzheimer disease using smartphone sensors

    ✓ Peer-reviewed Cognitive tests and assessment Journal of neuroengineering and rehabilitation

    Key finding: Our findings indicate that AD patients present impairments in some key functional abilities, such as gait, turning and sitting, sit to stand, and reaction time, both in mild and moderate AD. +3 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2019-08-14

    Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein

    ✓ Peer-reviewed Risk genes beyond APOE Acta neuropathologica

    Key finding: Both lesions develop in parallel in the human brain throughout the preclinical and clinical course of AD. +3 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2019-08-14

    Cognitive assessment tools for mild cognitive impairment screening

    ✓ Peer-reviewed Mild cognitive impairment Journal of neurology

    Key finding: However, there is currently no consensus on guidelines for routine screening of MCI, resulting in a considerable number of patients with undiagnosed MCI from community. +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2019-08-13

    Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors

    ✓ Peer-reviewed Tau biomarkers Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

    Key finding: Our research group has shown that extracellular levels of both Aβ and tau fluctuate during the normal sleep-wake cycle. +2 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2019-08-13

    Linking Molecular Pathways and Large-Scale Computational Modeling to Assess Candidate Disease Mechanisms and Pharmacodynamics in Alzheimer's Disease

    ✓ Peer-reviewed Long-term cohort studies Frontiers in computational neuroscience

    Key finding: In this work, we demonstrate how computational multi-scale brain modeling links phenomena of different scales and therefore identifies potential disease mechanisms leading the way to improved diagnostics and treatment. +3 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2019-08-12

    Organokines in disease

    ✓ Peer-reviewed Risk factors Advances in clinical chemistry

    Key finding: Metabolic syndrome represents comorbidities of central obesity, insulin resistance, dyslipidemia, hypertension and hyperglycemia associated with increased risk of type 2 diabetes, NAFLD, atherosclerotic CVD and neurodegenerative disease.

    Full summary, score breakdown and related studies → Original source

  19. 2019-08-12

    30-Day Emergency Department Revisit Rates among Older Adults with Documented Dementia

    ✓ Peer-reviewed Digital health tools Journal of the American Geriatrics Society

    Key finding: Dementia diagnoses were a significant predictor of 30-day ED revisits. +4 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2019-08-12

    A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ

    ✓ Peer-reviewed Genetics Neuron

    Key finding: Familial Alzheimer's disease (fAD) results from mutations in the amyloid precursor protein (APP) and presenilin (PSEN1 and PSEN2) genes. +1 more finding

    Full summary, score breakdown and related studies → Original source

  21. 2019-08-12

    Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers

    ✓ Peer-reviewed Biomarkers Annals of neurology

    Key finding: D-CAA M + showed greater age-dependent FLR PiB retention (p - , and serially imaged asymptomatic M + demonstrated greater longitudinal increases (p = 0.004). +2 more findings

    Full summary, score breakdown and related studies → Original source

  22. 2019-08-09

    Long-term exposure to air pollution and hospitalization for dementia in the Rome longitudinal study

    ✓ Peer-reviewed Risk factors Environmental health : a global access science source

    Key finding: Our results showed a positive association between exposure to NOx and O 3 and hospitalization for dementia and a negative association between NO 2 exposure and hospitalization for dementia. +4 more findings

    Full summary, score breakdown and related studies → Original source

  23. 2019-08-09

    Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial

    ✓ Peer-reviewed Drug development Diabetes care

    Key finding: In a large international cardiovascular outcome trial in people with type 2 diabetes and cardiorenal disease, linagliptin did not modulate cognitive decline over 2.5 years. +1 more finding

    Full summary, score breakdown and related studies → Original source

  24. 2019-08-09

    Defining Serious Illness Among Adult Surgical Patients

    ✓ Peer-reviewed End-of-life care Journal of pain and symptom management

    Key finding: We identified a consensus definition for serious illness in surgery. +1 more finding

    Full summary, score breakdown and related studies → Original source

  25. 2019-08-09

    A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain

    ✓ Peer-reviewed Inflammation and the immune system Alzheimer's research & therapy

    Key finding: This neurodegenerative disorder is associated with neuronal death and gliosis heavily impacting the cerebral cortex. +3 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →